Announcement Title | Change - Announcement of Cessation |
Date & Time of Broadcast | Apr 25, 2019 18:08 |
Status | New |
Announcement Sub Title | RETIREMENT OF NON-INDEPENDENT AND NON-EXECUTIVE DIRECTOR |
Announcement Reference | SG190425OTHRL9F5 |
Submitted By (Co./ Ind. Name) | Mr. Yet Kum Meng |
Designation | Chief Executive Officer and Executive Director |
Description (Please provide a detailed description of the event in the box below) | Retirement of Non-Independent and Non-Executive Director. This announcement has been prepared by the Company and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg). |
Additional Details | |
Name Of Person | Dr. Stephen Riady |
Age | 58 |
Is effective date of cessation known? | Yes |
If yes, please provide the date | 25/04/2019 |
Detailed Reason (s) for cessation | Dr Stephen Riady, who retired by rotation pursuant to Article 93 of Company's Constitution, did not seek for re-election at the Annual General Meeting of the Company held on 25 April 2019 in order for the Company to comply with provision 2.2 of the Code of Corporate Governance 2018. Dr Riady accordingly retired as a Director at the conclusion of the said Annual General Meeting. Based on its enquiries, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, other than as disclosed in this announcement, there are no material reasons for the cessation of Dr. Stephen Riady as Non-Independent and Non-Executive Director of the Company. |
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
Any other relevant information to be provided to shareholders of the listed issuer? | No |
Date of Appointment to current position | 17/07/2017 |
Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 2 |
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 2 |
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Non-Independent and Non-Executive Director. |
Role and responsibilities | The role and responsibilities as Non-Independent and Non-Executive Director. |
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Dr. Stephen Riady is the brother of Mr. James Tjahaja Riady who is a substantial shareholder of the Company. |
Shareholding interest in the listed issuer and its subsidiaries? | Yes |
Shareholding Details | Dr. Stephen Riady holds 100% of the issued share capital of Lippo Capital Group Limited, which is the holding company of Lippo Capital Holdings Company Limited. Lippo Capital Holdings Company Limited is an intermediate holding company of Pacific Landmark Holdings Limited. Pacific Landmark Holdings Company Limited and Admiralty Station Management Limited jointly hold Lippo ASM Asia Property Limited, the indirect holding company of Treasure International Holdings Pte. Ltd.("TIHPL"). TIHPL has a direct interest in 2,859,029,000 shares (64.35%) of OUE Lippo Healthcare Limited (the "Company"). Accordingly, Dr. Stephen Riady has a deemed interest in the Company's shares held by TIHPL and shares of the Company's subsidiaries indirectly or directly held by the Company. |
Past (for the last 5 years) | Please see attached Annex A. |
Present | Please see attached Annex A. |
Attachments